Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients

The drug 5-fluorouracil (5-Fu) is the critical composition of colorectal cancer (CRC) treatments. Prognostic and predictive molecular biomarkers for CRC patients (CRCpts) treated with 5-Fu-based chemotherapy can provide assistance for tailoring treatment approach. Here, we established a molecular bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lifeng, Tian, Bo, Liu, Wen, Liang, Haitao, You, Yong, Liu, Weizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004628/
https://www.ncbi.nlm.nih.gov/pubmed/35425715
http://dx.doi.org/10.3389/fonc.2022.855674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004628/
https://www.ncbi.nlm.nih.gov/pubmed/35425715
http://dx.doi.org/10.3389/fonc.2022.855674

Ejemplares similares